Conference LibraryGated
J Hematol Oncol 2026 · CAR-Macrophage review · Chen/Lin
"Chimeric antigen receptor macrophage (CAR-M) therapy has emerged as a highly promising novel platform in solid tumor immunotherapy. Leveraging its inherent tumor-homing capacity, potent phagocytic function, and potential to remodel the tumor microenvironment (TME), CAR-M offers…
- Type
- paper
- Domain
- oncology
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- Provenance
- m622_verify_wave_3_2026-05-16
- evidence_grade
- A
- category
- car_macrophage_review
- status
- verified
- instance_tag
- sunvax-antibody-2025
- clinical_claim_softening
- "review · preclinical/early-clinical CAR-M landscape · not intended to guide individual patient treatment choices"
- journal
- Journal of Hematology & Oncology
- year
- 2026
- authors
- Yizhao Chen,Ning Lin
- abstract_snippet
- "Chimeric antigen receptor macrophage (CAR-M) therapy has emerged as a highly promising novel platform in solid tumor immunotherapy. Leveraging its inherent tumor-homing capacity, potent phagocytic function, and potential to remodel the tumor microenvironment (TME), CAR-M offe
- pmid
- 41964040
- doi
- 10.1186/s13045-026-01792-9
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.